Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
State Research Center of Dermatovenerology and Cosmetology, Russian Ministry of Health, Moscow, Russia.
PLoS One. 2019 Jul 25;14(7):e0220339. doi: 10.1371/journal.pone.0220339. eCollection 2019.
The goal of this work was to study the phenotypic susceptibility and resistance determinants of N. gonorrhoeae isolates to beta-lactam antimicrobials (benzylpenicillin and ceftriaxone). A total of 522 clinical isolates collected in Russia in 2015-2017 were analysed for susceptibility using the agar dilution method. DNA loci involved in antimicrobial resistance were identified using DNA microarray analysis and sequencing. Resistance to benzylpenicillin remained high, with 7.7% of isolates resistant (MICpen > 1 mg/L) and 47.5% of isolates showing intermediate susceptibility (MICpen = 0.12-1 mg/L). The most frequent resistance determinant (72.4% isolates) was the Asp345 insertion in penA, both as a single mutation and in combination with other mutations, particularly with the substitution Leu421Pro in ponA (39.0%). Mutations affecting the influx and efflux of drugs were also found, including amino acid substitutions in PorB (26.8% isolates) and delA in the promoter region of mtrR (22.8%). The accumulation of mutations in chromosomal genes (penA, pon, porA, and mtrR) led to a stepwise increase in MICpen to values characteristic of intermediate resistance. The presence of blaTEM plasmids was found in 25 isolates (4.8%), resulting in a strong increase in resistance to penicillin (MICpen > 16 mg/L) compared with the chromosomal mutations; 23 plasmids were of the African type with TEM-1 beta-lactamase, and two plasmids were of the Toronto/Rio type with TEM-135 beta-lactamase. Only three isolates were found with reduced susceptibility to ceftriaxone, with MICcef = 0.12-0.25 mg/L. Sequencing of penA did not reveal mutations associated with resistance to third-generation cephalosporins, and the gene structure was non-mosaic. The majority of isolates (21 of 25) carrying the blaTEM plasmid also contained the conjugative plasmid with tetM (resistance to tetracyclines), consistent with previously reported data that the presence of the conjugative plasmid facilitates the transfer of other plasmids associated with antimicrobial resistance.
本研究旨在探究淋病奈瑟菌临床分离株对β-内酰胺类抗菌药物(青霉素和头孢曲松)的表型敏感性和耐药决定因素。使用琼脂稀释法对 2015-2017 年在俄罗斯收集的 522 株临床分离株进行药敏分析。采用 DNA 微阵列分析和测序技术鉴定与抗菌药物耐药相关的 DNA 基因座。青霉素耐药率仍较高,7.7%的分离株耐药(MICpen>1mg/L),47.5%的分离株中介度敏感(MICpen=0.12-1mg/L)。最常见的耐药决定因素(72.4%的分离株)是 penA 基因的 Asp345 插入,该插入既可以是单个突变,也可以与其他突变(尤其是 ponA 基因的 Leu421Pro 突变)共同存在。还发现了影响药物内外流的突变,包括 PorB 基因的氨基酸取代(26.8%的分离株)和 mtrR 启动子区的 delA(22.8%的分离株)。染色体基因(penA、pon、porA 和 mtrR)的突变积累导致 MICpen 逐渐增加到中介耐药的特征值。在 25 株(4.8%)分离株中发现了 blaTEM 质粒,与染色体突变相比,这导致对青霉素的耐药性显著增加(MICpen>16mg/L);23 个质粒为非洲型,含 TEM-1β-内酰胺酶,2 个质粒为多伦多/里约型,含 TEM-135β-内酰胺酶。仅发现 3 株对头孢曲松的敏感性降低,MICcef=0.12-0.25mg/L。penA 基因测序未发现与第三代头孢菌素耐药相关的突变,基因结构非镶嵌。携带 blaTEM 质粒的 25 株分离株中的 21 株也携带 tetM 基因(对四环素耐药)的可接合质粒,这与先前报道的数据一致,即可接合质粒的存在有助于携带其他抗菌药物耐药基因的质粒转移。